Cargando…

Percutaneous radiofrequency ablation on a Xp11.2 Translocation Renal Cell Carcinoma: A case report

Xp11.2 Translocation Renal Cell Carcinoma is a very rare subtype of renal neoplasm. The present report describes the first confirmed reported case of percutaneous ablation of this subtype of tumor. The patient presented an aggressive local recurrence 12 months after the procedure, with an infiltrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanas, Alexandre Fligelman, Rovella, Marcello Silveira, de Moura, Mauricio Ruettimann Liberato, Leite, Katia Ramos Moreira, Srougi, Miguel, de Menezes, Marcos Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574040/ https://www.ncbi.nlm.nih.gov/pubmed/33102099 http://dx.doi.org/10.1016/j.eucr.2020.101401

Ejemplares similares

Laparoscopic radiofrequency ablation-assisted enucleation of Xp11.2 translocation renal cell carcinoma: A case report
por: XU, LINFENG, et al.
Publicado: (2014)

Clinicopathological features of Xp11.2 translocation renal cell carcinoma
por: Lim, Bumjin, et al.
Publicado: (2015)

Xp11.2 translocation renal cell carcinomas in young adults
por: Xu, Linfeng, et al.
Publicado: (2015)

Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics
por: Dey, Biswajit, et al.
Publicado: (2016)

Bilateral Xp11.2 translocation renal cell carcinoma: a case report
por: Karashima, Takashi, et al.
Publicado: (2018)

Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma
por: Lu, Yanwen, et al.
Publicado: (2023)

Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype
por: Kmetec, Andrej, et al.
Publicado: (2014)

Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors
por: Dong, Jie, et al.
Publicado: (2021)

Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma
por: Kalita, Pranjal, et al.
Publicado: (2023)

Rapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report
por: Morii, Akihiro, et al.
Publicado: (2012)

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Chang, Kun, et al.
Publicado: (2017)

A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults
por: Shi, Qiancheng, et al.
Publicado: (2021)

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
por: Guo, Wei, et al.
Publicado: (2023)

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)

Surgical treatment for Xp11.2 translocation renal cell carcinoma with venous thrombus: A STROBE-compliant study
por: Ge, Liyuan, et al.
Publicado: (2019)

Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide–chlorambucil conjugate
por: Funasaki, Shintaro, et al.
Publicado: (2022)

Managing the inflammatory response after cardiopulmonary bypass: review of the studies in animal models
por: Liguori, Gabriel Romero, et al.
Publicado: (2014)

Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function
por: Huh, Hyuk, et al.
Publicado: (2017)

Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis
por: Zhu, Yiqi, et al.
Publicado: (2021)

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature
por: Armah, Henry B, et al.
Publicado: (2009)

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
por: Agizamhan, Sezim, et al.
Publicado: (2018)

MicroRNA‐204‐5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma
por: Kurahashi, Ryoma, et al.
Publicado: (2019)

Gender difference analysis of Xp11.2 translocation renal cell carcinomas’s attack rate: a meta-analysis and systematic review
por: Zhuang, Wenyuan, et al.
Publicado: (2020)

Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma
por: Cheng, Jun, et al.
Publicado: (2020)

Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?
por: Ma, Wenliang, et al.
Publicado: (2020)

Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis—A Systematic Review and Pooled Analysis
por: Wu, Yuqing, et al.
Publicado: (2021)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
por: Ge, Yan, et al.
Publicado: (2021)

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
por: Huang, Wenpeng, et al.
Publicado: (2023)

Microwave ablation: initial experience in Brazil
por: Rovella, Marcello Silveira, et al.
Publicado: (2020)

MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)]
por: Hora, Milan, et al.
Publicado: (2014)

Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Wang, Wei, et al.
Publicado: (2014)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Rare Case Report with Review of the Literature
por: Ahluwalia, Puneet, et al.
Publicado: (2013)

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas
por: He, Jian, et al.
Publicado: (2015)

Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China
por: Liu, Ning, et al.
Publicado: (2020)

Case Report: TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma (TRCC) – A Case Study and Review of the Literature
por: Miroński, Ignacy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5mr31hgf54eqade6jeambopr6j